Back to Top
Omalizumab Biosimilar - Research Grade
$315.00 - $19,890.00
Omalizumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Species Reactivity
Human
Target
IgE
Concentration
1.0 - 5.0 mg/ml
Isotype
Human IgG1 Kappa
Host
Humanized
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Storage
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity
Detects human IgE. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Omalizumab.
Shipping Conditions
Blue ice
Background
Immunoglobulin E (IgE) is the antibody isotype that orchestrates allergic and atopic responses, making it a focal target in allergy and immunology research. This research-grade anti-human IgE recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of omalizumab, designed around the IgE target for research use only. Manufactured to in vivo standards as an ultra-pure, low-endotoxin human IgG1-kappa, it is supplied in scalable milligram to gram quantities for high-throughput and bulk laboratories. The antibody supports preclinical applications including IgE-blocking assays, in vitro screening of allergic pathways, and in vivo models of allergic inflammation.
Other Names
Immunoglobulin E
Uniprot
P01854
Buffer
ICH3001-100ml
ICH3002-100ml
ICH3003-100ml
Sequence
https://www.imgt.org/mAb-DB/
Write Your Own Review





















